Chugai Venture Fund
Profile, fund size and portfolio
Chugai Venture Fund is the corporate venture arm of Chugai Pharmaceutical, a pharmaceutical and biotech company. It was founded in 2023 and is based in Boston, United States. It invests from seed to Series A. Sectors it names: biotech and life sciences, artificial intelligence.
- Fund sizeS6
- USD 200M
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Series A |
| Sectors | Biotech and life sciences, Artificial intelligence |
| Geography | North America, Europe, Asia |
| Offices | Boston, United States |
Sources: S3 Chugai Venture Fund: Investment scope; S7 Chugai press release: Chugai establishes corporate venture capital (2023-06-27).
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | USD 200M | Fund size | Stated by the firm or its parent | S6 |
| Companies on the firm's portfolio page | 6 | companies | Counted from the firm's own list | S4 |
Sources: S6 Chugai press release: Chugai Venture Fund starts investment activities (2023-12-19); S4 Chugai Venture Fund: Portfolio.
Where it invests and who leads it
LeadersS2
- John GustofsonPresidentFind on LinkedInFirm page
- Mike DialManaging DirectorFind on LinkedInFirm page
- Taku FukuzawaPrincipalFind on LinkedInFirm page
- Tatsushi KodamaAssociateFind on LinkedInFirm page
- Yoshikazu AndoAssociateFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Chugai Pharmaceutical | Single source | S6 |
| Parent industry | Pharmaceuticals and biotech | Single source | S6 |
| Founded | 2023 | Single source | S6 |
| Headquarters | Boston, United States | Single source | S5 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S6 |
| Headline size | USD 200M (Fund size) | Single source | S6 |
| People on the team page | 7 | Single source | S2 |
| Stages | Seed, Series A (inferred from announced rounds) | Estimate | S3 |
For founders
Fund vehicles
| Vehicle | Size | Year | Source |
|---|---|---|---|
| Chugai Venture Fund | USD 200M | 2023 | S6 |
History
Portfolio
The firm's portfolio page lists 6 companies.S4
Every company on the Chugai Venture Fund list
6 companies, as listed on the firm's own website.S4 Read the firm's list.
- Dualitas Therapeutics
- Hyku Biosciences
- Leal Therapeutics
- Repertoire Immune Medicines
- Stylus Medicine
- Ten63 Therapeutics
Official pages
Read the firm's own pages for current information.
- Website www.chugaiventurefund.com/
- Portfolio www.chugaiventurefund.com/portfolio
- LinkedIn company page www.linkedin.com/company/chugai-venture-fund-cvf/
Sources
- S1Chugai Venture Fund: HomeFirm
- S2Chugai Venture Fund: TeamFirm
- S3Chugai Venture Fund: Investment scopeFirm
- S4Chugai Venture Fund: PortfolioFirm
- S5Chugai Venture Fund: ContactFirm
- S6Chugai press release: Chugai Venture Fund starts investment activities (2023-12-19)Parent company
- S7Chugai press release: Chugai establishes corporate venture capital (2023-06-27)Parent company
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Chugai Venture Fund or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.